NCT02164916 2020-12-30S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal CancerSWOG Cancer Research NetworkPhase 2 Completed106 enrolled 16 charts